$4.69 -0.15 (-3.10%)
2/10/2012 3:59 PM

DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA)

CAPS Rating: 3 out of 5

A dermatology company, which is engaged in the development and marketing Levulan photodynamic therapy and other products for common skin conditions.

Featured Broker Partners


Advertisement